Tokyo, Nov. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063478) titled 'Study to evaluate the effects of the test food on the skin in healthy subjects' on Nov. 17.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - EP-DataWeave Co., Ltd.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the effects on the skin and the safety of consuming the test food for eight consecutive weeks, using a placebo as a control.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Take the test food for eight consecutive weeks.
Interventions/Control_2 - Take the placebo for eight consecutive weeks.
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - (1) Healthy men and women aged 18 to 64 years at the time of obtaining consent
(2) Subjects who perceive their skin to be dry
(3) Subjects who fully understand the purpose and details of the study and voluntarily consent to participate
Key exclusion criteria - Subjects
(1) who habitually consume foods or supplements rich in the active ingredient
(2) who habitually consume foods, pharmaceuticals, or supplements that affect the skin
(3) who habitually use cosmetic products containing ingredients that could affect the study
(4) who have undergone cosmetic medical procedures on the area to be measured
(5) who have undergone cosmetic medical procedures or hormone replacement therapy within one year of the pre-examination
(6) who have undergone procedures affecting the skin at the measurement site within one month of the pre-examination, or who plan to undergo such procedures
(7) who have acquired a suntan within one month of the pre-examination, or who plan to do so
(8) who wash the measurement site with excessive rubbing
(9) who habitually use bath additives
(10) with a disease of the skin at the measurement site
(11) who have body hair on the skin at the measurement site
(12) who exhibit hay fever symptoms on the skin
(13) who experience skin roughness in the area to be measured around the time of menstruation
(14) who habitually consume excessive amounts of alcohol
(15) who smoke or who have smoked within one month of the pre-examination
(16) with an irregular daily routine
(17) planning to travel overseas or take long domestic trips
(18) who have asthma or are likely to develop it
(19) with a serious illness or a history of such illness
(20) at risk of developing an allergy by participating in the study
(21) whose pre-study test results show values significantly outside the reference range
(22) who have participated in other clinical studies within one month prior to obtaining informed consent, or who plan to participate
(23) who are pregnant or plan to become pregnant or breastfeed
(24) deemed unsuitable as subjects based on clinical test results, cardiopulmonary function or their responses to the lifestyle questionnaire
(25) deemed unsuitable as subjects by the principal investigator
Target Size - 100
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 10 Month 22 Day
Anticipated trial start date - 2026 Year 11 Month 18 Day
Last follow-up date - 2027 Year 03 Month 19 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072643
Disclaimer: Curated by HT Syndication.